These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 188530)

  • 21. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 22. International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants.
    Barnett PV; Pullen L; Williams L; Doel TR
    Vaccine; 1996 Sep; 14(13):1187-98. PubMed ID: 8961504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Riems foot-and-mouth disease oil emulsion vaccines for swine. 2. Use of foot-and-mouth 2-component oil emulsion vaccines in practice].
    Nöckler A; Thalmann G; Haack P; Nehmzow P; Poewe R; Pietzsch E; Seils G
    Arch Exp Veterinarmed; 1990; 44(2):183-8. PubMed ID: 2167045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of anti-foot-and-mouth disease vaccine in oil adjuvant in young cattle].
    Brun A; Chappuis G; Favre H; Roulet C; Terré J
    Dev Biol Stand; 1976; 35():117-22. PubMed ID: 198277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study on the immune response of sheep to foot and mouth disease virus vaccine type Asia-1 prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):117-24. PubMed ID: 1314158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of antibody-synthesizing cells in mice and swine by means of local hemolysis in gel following immunization with foot-and-mouth disease virus and vaccine].
    Wittmann G; Reda I
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):420-5. PubMed ID: 4154623
    [No Abstract]   [Full Text] [Related]  

  • 30. [Riems foot-and-mouth disease oil emulsion vaccines for swine. 1. Development and testing of highly effective and well-tolerated foot-and-mouth disease vaccine for swine using Dessauer oil adjuvants].
    Nöckler A; Thalmann G; Bartels T; Haack P
    Arch Exp Veterinarmed; 1990; 44(2):171-82. PubMed ID: 2167044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of young pigs to foot-and-mouth disease oil emulsion vaccination in the presence and absence of maternally derived neutralising antibodies.
    Francis MJ; Black L
    Res Vet Sci; 1986 Jul; 41(1):33-9. PubMed ID: 3020657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of FMD vaccines with polycationic-nucleic acid complexes.
    Maes RF; Vieira A; Gomes I; Auge de Mello P; Bernal Lopez C; Costa Freitas K
    Arch Virol; 1977; 55(4):275-85. PubMed ID: 597039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of foot-and-mouth disease virus antibody using counterimmunoelectrophoresis and serum neutralisation tests.
    Rao MV; Suryanarayana VV; Bhanumati N; Rao DR; Madhusudan P; Rao BU
    Trop Anim Health Prod; 1985 May; 17(2):89-92. PubMed ID: 2992139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody response of tropical range cattle to foot-and-mouth disease virus. II. Evaluation of response to O-1, A-27, and A-18 subtypes.
    Arias CA; Hanson RP; de Gerardino AG
    Dev Biol Stand; 1976; 35():215-20. PubMed ID: 198289
    [No Abstract]   [Full Text] [Related]  

  • 35. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines.
    Dalsgaard K
    Arch Gesamte Virusforsch; 1974; 44(3):243-54. PubMed ID: 4365900
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations of cattle, goats and pigs after administration of synthetic interferon inducers and subsequent exposure to foot and mouth disease virus.
    McVicar JW; Richmond JY; Campbell CH; Hamilton LD
    Can J Comp Med; 1973 Oct; 37(4):362-8. PubMed ID: 4356316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production.
    Iyer AV; Ghosh S; Singh SN; Deshmukh RA
    Vaccine; 2000 Dec; 19(9-10):1097-105. PubMed ID: 11137244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foot-and-mouth disease: a vaccine study.
    McKercher PD; Callis JJ
    Dev Biol Stand; 1976; 35():123-33. PubMed ID: 198278
    [No Abstract]   [Full Text] [Related]  

  • 40. [Post-vaccinal immunity against heterologous subtypes of the foot-and-mouth disease virus].
    Sobko AI; Sokolov LN; Mishchenko VA; Maslova NS; Dudnikov AI
    Veterinariia; 1977 Sep; (9):42-4. PubMed ID: 202059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.